Internal Server Error

Nucaps Nanotechnology - About the company

Nucaps Nanotechnology is a seed company based in Noain (Spain), founded in 2016. It operates as a Provider of encapsulation technology for developing nanocapsules and biocapsules. Nucaps Nanotechnology has raised $440K in funding from UN I+D+i Tech Transfer. The company has 2649 active competitors, including 877 funded and 627 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.

Company Details

NUCAPS provides encapsulation technology for developing nanocapsules and biocapsules. Its product includes a protein-based dry powder that can be filled in a capsule/sachet/pill. It is claimed to increase the solubility of the active compound and form stable suspensions in liquids. Additionally, it provides encapsulation services for bioactive and probiotics capsules. Its offerings have applications in the nutrition, food, pharmaceutical, cosmetics, and healthcare industries. The company also provides IP licenses for applications of its technology in multiple markets and owns 4 international patents for its protein-based nano/biocapsules. The company was found by a collaboration between CNTA, IDIFARMA, and the University of Navarra.
Social
XFacebook
Email ID
*****@nucapsnanotechnology.com
Key Metrics
Founded Year
2016
Location
Noain, Spain
Stage
Seed
Total Funding
$440K in 3 rounds
Ranked
Employee Count
20 as on Sep 30, 2026
Similar Companies
Sign up to download Nucaps Nanotechnology's company profile

Nucaps Nanotechnology's funding and investors

Nucaps Nanotechnology has raised a total funding of $440K over 3 rounds. Its first funding round was on 2020. Its latest funding round was a Grant (prize money) round on Sep 11, 2024 for $*****. 1 investor participated in its latest round. Nucaps Nanotechnology has 6 institutional investors.

Here is the list of recent funding rounds of Nucaps Nanotechnology:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Sep 11, 2024
3865934
Grant (prize money)
2604297
3709998
6142848
8369185
Nov 22, 2023
7763676
Conventional Debt
4108904
3913129
8409225
2020
9512
Seed
3736
5677
3286
lockAccess funding benchmarks and valuations. Sign up today!

Nucaps Nanotechnology's founders and board of directors

Founder? Claim Profile

Nucaps Nanotechnology's employee count trend

Nucaps Nanotechnology has 20 employees as of Sep 26. Here is Nucaps Nanotechnology's employee count trend over the years:
Employee count trend for Nucaps Nanotechnology
lockUncover Nucaps Nanotechnology's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Nucaps Nanotechnology's Competitors and alternates

Top competitors of Nucaps Nanotechnology include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of Nucaps Nanotechnology, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
82/100
2nd
Logo for Tango Therapeutics
Tango Therapeutics
2017, Cambridge (United States), Public
Developer of drugs for the treatment of cancer
$165M
72/100
3rd
Logo for Elicio
Elicio
2012, Cambridge (United States), Public
Developer of vaccines for treating cancer
$47.4M
72/100
4th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
71/100
5th
Logo for BioNTech
BioNTech
2008, Mainz (Germany), Public
Developer of immunotherapeutics for the treatment of cancer and other diseases
$861M
71/100
6th
Logo for Erasca
Erasca
2018, San Diego (United States), Public
Developer of small molecule based therapeutics for cancer
$300M
71/100
7th
Logo for Philogen
Philogen
1996, Sovicille (Italy), Public
Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders
$69.7M
70/100
8th
Logo for Ideaya Biosciences
Ideaya Biosciences
2015, San Francisco (United States), Public
Developer of oncology-focused precision medicine using molecular diagnostics
$157M
70/100
9th
Logo for Deciphera
Deciphera
2003, Waltham (United States), Acquired
Developer of type 2 kinase inhibitors for treating cancer
$173M
70/100
10th
Logo for Sana Biotechnology
Sana Biotechnology
2018, Seattle (United States), Public
Developer of engineered cell therapies for treating various human diseases
$821M
69/100
884th
Logo for Nucaps Nanotechnology
Nucaps Nanotechnology
2016, Noain (Spain), Seed
Provider of encapsulation technology for developing nanocapsules and biocapsules
$440K
38/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Nucaps Nanotechnology's competitors? Click here to see the top ones

Nucaps Nanotechnology's Investments and acquisitions

Nucaps Nanotechnology has made no investments or acquisitions yet.

Reports related to Nucaps Nanotechnology

Here is the latest report on Nucaps Nanotechnology's sector:

News related to Nucaps Nanotechnology

•
Sodena facilitates the financing round of Nucaps with a loan of €150,000Webcapitalriesgo•Nov 22, 2023•Sodena, Nucaps Nanotechnology
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Nucaps Nanotechnology

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford